LDL-cholesterol decrease by anti-PCSK9 monoclonal antibodies: systematic review, meta-analysis and meta-regression of randomized controlled trials
Event:
ESC Congress 2020
Topic:
Lipid-Lowering Agents
Session:
Pharmacology and Pharmacotherapy ePosters
